Medtronic received FDA approval for its SynchroMed II myPTM Personal Therapy Manager for chronic pain patients.
Here are five things to know:
1. myPTM works with the SynchroMed II Intrathecal Drug Delivery system, which delivers medication directly to the fluid around the spinal cord for chronic pain relief.
2. The SynchroMed II system is Medtronic's implantable pain pump, which is designed to provide long-term pain relief at lower doses and with fewer side effects than oral pain medications.
3. myPTM is an application on a touchscreen Samsung J3 smart device, which allows healthcare providers to set daily therapeutic doses and allow for on-demand drug delivery within pre-established limits.
4. The application offers clear bolus delivery, access to therapeutic details and lockout alerts if patient demand exceeds prescribed limits. Physicians can also access reports that provide insights necessary to track progress on patients' therapeutic goals.
5. Medtronic aims to reduce the need for oral opioids to combat the opioid epidemic.